01
Ambria
ICU nurses shouldn't have to manually measure what machines can monitor continuously.
The Problem
Urine output is one of the most critical signals in an ICU, a leading indicator of shock, kidney failure, and fluid imbalance. Yet in most hospitals, nurses still measure it manually, every hour, for every catheterized patient. The process is inaccurate, biohazardous, and occupies time that should be spent on higher-acuity care. Physicians make decisions on data they know is unreliable. The gap between what's clinically needed and what the workflow delivers is enormous.
My Role
Co-Founder and Product Lead, owning the full product lifecycle from clinical discovery through IP transfer. Drove user research, product strategy, requirements definition, iterative design, and the GTM and business case for Penn Medicine's innovation pipeline.
How I Built It
Outcome
80% reduction in urine disposal time. $98,100 in annual savings per ICU. All IP transferred to University of Pennsylvania. Ambria is currently in refinement at Penn Medicine Innovation Center on the FDA approval pathway.